20 results
8-K
EX-10.1
ORTX
Orchard Therapeutics plc
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
or entity onto Company premises or into Company workspaces.
4. Commitment to Company; Avoidance of Conflict of Interest. While an employee … of the Company or his or her designee at such time as any activity of either the Company or another business presents me with a conflict of interest
8-K
EX-10.1
n89bcd4c95ym uyvx28z
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
8-K
EX-3.1
my0zzr96iqz7 vnkp8
19 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:09pm
10-Q
EX-10.1
5elmksjg19tlx08p3
7 May 20
Quarterly report
4:03pm
DEF 14A
dtti ruuo3
29 Apr 20
Definitive proxy
4:02pm
PRE 14A
3xa3b7 8x
14 Apr 20
Preliminary proxy
4:46pm
10-K
EX-10.15
4m4kr f8rebakd94
27 Feb 20
Annual report
4:02pm
10-K
EX-10.14
fhphk3b6ndkeax9q7 gg
27 Feb 20
Annual report
4:02pm
10-K
EX-10.16
r99ttzdw3
27 Feb 20
Annual report
4:02pm
20-F
EX-1.1
rjj7 4fc2
22 Mar 19
Annual report (foreign)
8:02am
F-1/A
EX-10.11
p94ri75k5wknp4q
23 Oct 18
Registration statement (foreign) (amended)
6:15am
F-1/A
EX-10.5
wzb05 efbrlkg4h5f
23 Oct 18
Registration statement (foreign) (amended)
6:15am
F-1/A
EX-3.1
plwhzah 7w5hbdvx
23 Oct 18
Registration statement (foreign) (amended)
6:15am
F-1
EX-10.5
mlixoycv
4 Oct 18
Registration statement (foreign)
4:48pm
DRS
EX-10.5
hqszah67h rw7fb3n95
6 Aug 18
Draft registration statement
12:00am
- Prev
- 1
- Next